BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 36584476)

  • 21. Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells.
    Usui T; Yanagihara K; Tsukasaki K; Murata K; Hasegawa H; Yamada Y; Kamihira S
    Retrovirology; 2008 Apr; 5():34. PubMed ID: 18426605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
    Sakihama S; Morichika K; Saito R; Miyara M; Miyagi T; Hayashi M; Uchihara J; Tomoyose T; Ohshiro K; Nakayama S; Nakachi S; Morishima S; Sakai K; Nishio K; Masuzaki H; Fukushima T; Karube K
    Cancer Sci; 2021 Mar; 112(3):1300-1309. PubMed ID: 33426772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma.
    Phillips AA
    Curr Opin Virol; 2023 Feb; 58():101289. PubMed ID: 36584476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL).
    Ahmadi Ghezeldasht S; Blackbourn DJ; Mosavat A; Rezaee SA
    Crit Rev Clin Lab Sci; 2023 May; 60(3):189-211. PubMed ID: 36593730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HTLV-1 persistent infection and ATLL oncogenesis.
    Zuo X; Zhou R; Yang S; Ma G
    J Med Virol; 2023 Jan; 95(1):e28424. PubMed ID: 36546414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ.
    Giam CZ; Semmes OJ
    Viruses; 2016 Jun; 8(6):. PubMed ID: 27322308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
    Ohshima K
    Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects.
    Nosaka K; Matsuoka M
    Cancer Sci; 2021 May; 112(5):1688-1694. PubMed ID: 33630351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HTLV-1 and associated adult T-cell leukemia/lymphoma.
    Mahieux R; Gessain A
    Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia/lymphoma.
    Yoshimitsu M; White Y; Arima N
    Recent Results Cancer Res; 2014; 193():211-25. PubMed ID: 24008301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NF-κB signaling mechanisms in HTLV-1-induced adult T-cell leukemia/lymphoma.
    Harhaj EW; Giam CZ
    FEBS J; 2018 Sep; 285(18):3324-3336. PubMed ID: 29722927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors.
    Harrod R
    Retrovirology; 2019 Sep; 16(1):25. PubMed ID: 31492165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T-Cell Leukemia Virus Type 1 Envelope Protein: Post-Entry Roles in Viral Pathogenesis.
    Maksimova V; Panfil AR
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.
    Rauch DA; Ratner L
    Viruses; 2011 Jun; 3(6):886-900. PubMed ID: 21994759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular targeting for treatment of human T-lymphotropic virus type 1 infection.
    Soltani A; Hashemy SI; Zahedi Avval F; Soleimani A; Rafatpanah H; Rezaee SA; Griffith R; Mashkani B
    Biomed Pharmacother; 2019 Jan; 109():770-778. PubMed ID: 30551530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia.
    El Hajj H; Bazarbachi A
    Front Immunol; 2022; 13():957535. PubMed ID: 35935975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stem cell therapy for HTLV-1 induced adult T-cell leukemia/lymphoma (ATLL): A comprehensive review.
    Gholamzad A; Khakpour N; Gholamzad M; Roudaki Sarvandani MR; Khosroshahi EM; Asadi S; Rashidi M; Hashemi M
    Pathol Res Pract; 2024 Mar; 255():155172. PubMed ID: 38340584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insight into the oncogenic mechanism of the retroviral oncoprotein Tax.
    Cheng H; Ren T; Sun SC
    Protein Cell; 2012 Aug; 3(8):581-9. PubMed ID: 22865346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma.
    O'Donnell JS; Hunt SK; Chappell KJ
    Lancet Haematol; 2023 Jul; 10(7):e539-e548. PubMed ID: 37407143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.